Book a Consultation How It Works The higher concentration provides intensified therapeutic effects across all major healing pathways for maximum regenerative potential
Healthcare professionals cannot provide informed guidance on BPC-157 dosing or monitoring due to the absence of clinical evidence
CJC-1295 and ipamorelin dosing is based on published human PK/PD data and long-running community protocols
BPC-157 has become one of the most intensively studied synthetic peptides in European laboratories over the past three decades, with hundreds of peer-reviewed publications examining its effects on tissue repair, cytoprotection, and vascular function in preclinical models
Other Conditions BPC-157 May Help in Dogs Joint disease gets most of the attention, but BPC-157 has a wider range of potential applications in dogs
Published Nexus variants include 5mg, 10mg, 50mg